Hyperfine Swoop vs Subtle Medical
Subtle Medical's 11 openFDA clearances cover software that the vendor says works on existing MR, PET and CT scanners. It describes SubtleHD(MR) as up to 80% faster MRI sequences and SubtleHD(PET) as up to 75% faster scans, and says it is deployed on over 1,300 scanners. AiMIFY, built with Bracco, targets contrast-enhanced brain MRI at a lower gadolinium dose. A center with an MR booking backlog is the target of those vendor-claimed speed-ups, and no price is public. Hyperfine builds reconstruction into the scanner: Optive AI reached its installed base in July 2025 and carries CE and UKCA marks from August 2025. A department that wants contrast-enhanced brain MRI at a lower dose will not get it from Hyperfine, because a review of Swoop use in Malawi notes no contrast-enhanced T1. Which of Swoop's 510(k) records covers Optive AI is unclear.
Radiology · Reviewed November 2, 2026

Hyperfine Swoop
by Hyperfine
Portable 0.064T brain MRI (Swoop) with Optive AI image reconstruction. Also BrainInsight AI brain morphometry.

Subtle Medical
by Subtle Medical
Vendor-neutral deep-learning software that improves MR, PET and CT image quality on faster or lower-dose protocols.
When to pick each one
Hyperfine Swoop
- Optive AI reconstruction built into a portable 0.064T MRI
- Company reports cash runway into 2028
- Optive AI rolled out to its installed base in July 2025
Subtle Medical
- SubtleHD(MR), vendor claims up to 80% faster sequences
- Vendor says it works on existing MR, PET and CT scanners
- 11 FDA clearances on openFDA
Score
Each row shows points earned of points available under the published rubric.
Hyperfine Swoop
47of 100
Subtle Medical
37of 100
| Dimension | Hyperfine Swoop | Subtle Medical | Difference |
|---|---|---|---|
| FDA clearance | 18 / 18 | 18 / 18 | 0 |
| HIPAA / SOC2 / BAA | 0 / 10 | 0 / 10 | 0 |
| EHR integrations (count) | 0 / 4.2 | 0 / 4.2 | 0 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 0 / 2.4 | 0 / 2.4 | 0 |
| Peer-reviewed papers | 12.7 / 18.2 | 7.3 / 18.2 | +5.5 |
| RCT / meta-analysis / systematic review | 0 / 7.8 | 0 / 7.8 | 0 |
| Funding & adoption signal | 6 / 12 | 3 / 12 | +3 |
| Pricing transparency | 2.5 / 5 | 2.5 / 5 | 0 |
| Years in market | 0 / 6 | 0 / 6 | 0 |
Scroll horizontally to see every column.
Pricing
Hyperfine Swoop
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. Per the FY2025 10-K summary, systems are owned, with an annual software, service and support agreement after a one-year warranty on 36- or 60-month terms. Dollar amounts were not found. |
Subtle Medical
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. Billing period, trial and refund not stated. |
Evidence
Hyperfine Swoop
FDA decisions
K262622 (opens in new tab)510(k)2026-08-19
Swoop
K253489 (opens in new tab)510(k)2025-12-12
Swoop
K250236 (opens in new tab)510(k)2025-05-30
Swoop (V2)
K251276 (opens in new tab)510(k)2025-05-21
Swoop
K240944 (opens in new tab)510(k)2024-07-16
Swoop
Show 12 more
K232760 (opens in new tab)510(k)2023-10-06
Swoop
K230208 (opens in new tab)510(k)2023-02-22
Swoop
K223268 (opens in new tab)510(k)2022-12-16
BrainInsight
K223247 (opens in new tab)510(k)2022-12-06
Swoop
K221923 (opens in new tab)510(k)2022-07-28
Swoop
K220815 (opens in new tab)510(k)2022-07-19
BrainInsight
K221393 (opens in new tab)510(k)2022-06-10
Swoop
K212456 (opens in new tab)510(k)2021-11-17
Swoop
K211818 (opens in new tab)510(k)2021-07-07
Swoop
K202414 (opens in new tab)510(k)2021-01-07
BrainInsight
K201722 (opens in new tab)510(k)2020-08-11
Hyperfine POC MRI
K192002 (opens in new tab)510(k)2020-02-06
Lucy POC MRI
Peer-reviewed
4 PubMed records name Hyperfine Swoop.
- Super resolution using sparse sampling at portable ultra-low field MR. (opens in new tab)
- Tips and challenges for clinical use and interpretation of low field portable MRI in neuroimaging. (opens in new tab)
- Case-based review of low-field MRI in resource-constrained settings: a clinical perspective from Malawi. (opens in new tab)
Subtle Medical
FDA decisions
K254120 (opens in new tab)510(k)2026-05-15
SubtleHD-CT 1.x
K254013 (opens in new tab)510(k)2026-05-14
SubtleHD-PET 1.x
K243250 (opens in new tab)510(k)2025-02-12
SubtleHD 1.x
K240290 (opens in new tab)510(k)2024-08-21
AiMIFY 1.x
K241329 (opens in new tab)510(k)2024-07-11
SubtleSYNTH 1.x
Show 6 more
K233699 (opens in new tab)510(k)2024-04-29
SubtleREFORMAT 1.x
K223623 (opens in new tab)510(k)2023-05-11
SubtleMR 2.3.x
K211964 (opens in new tab)510(k)2021-09-28
SubtlePET
K203182 (opens in new tab)510(k)2021-02-26
SubtleMR
K191688 (opens in new tab)510(k)2019-09-16
SubtleMR
K182336 (opens in new tab)510(k)2018-11-30
SubtlePET
Peer-reviewed
1 PubMed record names Subtle Medical.
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | Hyperfine Swoop | Subtle Medical |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | Not specified |
| Founded | n/a | n/a |
| HQ | US | n/a |
Scroll horizontally to see both columns.
Common questions
Open the full radiology comparison
Acute-care triage, mammography screening, CCTA plaque analysis, mobile MRI. 30+ FDA-cleared platforms across stroke, oncology, cardiac. Enterprise sales only — we compared what's deployed where.
